Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation with Chloroquine/Hydroxychloroquine for COVID-19
NCT04447534Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of zinc in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Primary endpoint: Number of patients with improvement or mortality at 2 weeks. Started Jun 2020; status: completed.
02
Drugs
zinc
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04447534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447534.